FDA approves 1st mRNA flu shot, from Moderna
Categories: health
Quick Summary
The FDA has approved the first mRNA flu shot, developed by Moderna, marking a significant milestone in the development of mRNA technology for infectious diseases beyond COVID-19. This new flu vaccine is expected to provide broader protection against multiple flu strains and has been shown to be safe and effective in clinical trials.
Key Points
- The FDA has approved the first mRNA flu shot, developed by Moderna.
- This approval marks a significant milestone in the development of mRNA technology for infectious diseases beyond COVID-19.
- The new flu vaccine is expected to provide broader protection against multiple flu strains.
- Moderna's mRNA flu shot has been shown to be safe and effective in clinical trials.
View Original Article
This summary is AI generated and may be inaccurate